Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
ECCO2R is not approved by the Food and Drug Administration in the US. Multiple clinical trials are underway to explore its utility in treating chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS). Like any extracorporeal device, this is a very resource-intensive and expensive technology. With the potential for complications, there is a need for close monitoring by physicians, nurses, ECMO specialists, and perfusionists with specialized training. Two other ECCOR2 devices are undergoing clinical trials, including respiratory dialysis and gas exchange catheters; the former removes the carbon dioxide in wet form using available dialysis equipment, increasing hopes of decreasing the cost and potentially reducing the complication rates.